P
Pattie S. Green
Researcher at University of Washington
Publications - 66
Citations - 11034
Pattie S. Green is an academic researcher from University of Washington. The author has contributed to research in topics: Neuroprotection & Estrogen. The author has an hindex of 41, co-authored 66 publications receiving 10357 citations. Previous affiliations of Pattie S. Green include University of Wisconsin-Madison & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
Suzanne Craft,Laura D. Baker,Thomas J. Montine,Satoshi Minoshima,G. Stennis Watson,Amy Claxton,Matthew Arbuckle,Maureen Callaghan,Elaine Tsai,Stephen R. Plymate,Pattie S. Green,James B. Leverenz,Donna J. Cross,Brooke Gerton +13 more
TL;DR: These results support longer trials of intranasal insulin therapy for patients with amnestic mild cognitive impairment and patients with AD.
Journal ArticleDOI
Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
Laura D. Baker,Laura L. Frank,Karen E. Foster-Schubert,Pattie S. Green,Charles W. Wilkinson,Anne McTiernan,Stephen R. Plymate,Mark A. Fishel,G. Stennis Watson,Brenna Cholerton,Glen E. Duncan,Pankaj D. Mehta,Suzanne Craft +12 more
TL;DR: Six months of high-intensity aerobic exercise had sex-specific effects on cognition, glucose metabolism, and hypothalamic-pituitary-adrenal axis and trophic activity despite comparable gains in cardiorespiratory fitness and body fat reduction.
Journal ArticleDOI
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar,Subramaniam Pennathur,Pattie S. Green,Sina A. Gharib,Andrew N. Hoofnagle,Marian C. Cheung,Jaeman Byun,Simona Vuletic,Sean Y. Kassim,Pragya Singh,Helen Chea,Robert H. Knopp,John D. Brunzell,Randolph L. Geary,Alan Chait,Xue Qiao Zhao,Keith B. Elkon,Santica M. Marcovina,Paul M. Ridker,John F. Oram,Jay W. Heinecke +20 more
TL;DR: The observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.
Journal ArticleDOI
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Mark A. Reger,G. S. Watson,Pattie S. Green,Charles W. Wilkinson,Laura D. Baker,Brenna Cholerton,Mark A. Fishel,S. R. Plymate,John C.S. Breitner,William DeGroodt,P. Mehta,P. Mehta,Suzanne Craft +12 more
TL;DR: The results of this pilot study support further investigation of the benefits of intranasal insulin for patients with Alzheimer disease, and suggest that intran asal peptide administration may be a novel approach to the treatment of neurodegenerative disorders.
Journal ArticleDOI
Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study
G. Stennis Watson,Brenna Cholerton,Mark A. Reger,Laura D. Baker,Stephen R. Plymate,Stephen R. Plymate,Sanjay Asthana,Mark A. Fishel,J. Jacob Kulstad,Pattie S. Green,David G. Cook,David G. Cook,David G. Cook,Steven E. Kahn,Steven E. Kahn,Michelle L. Keeling,B. S. Suzanne Craft +16 more
TL;DR: Preliminary support is provided that rosiglitazone may offer a novel strategy for the treatment of cognitive decline associated with AD, consistent with recent reports that plasma Aβ42 decreases with progression of AD.